Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03591861 · ClinicalTrials.gov registry record · NA
Therapeutic Targeting of Sex Differences in Pediatric Brain Tumor Glycolysis
A NA study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03591861 is a NA study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 2 participants.
The verdict
NCT03591861, a NA study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The investigators will develop the concept of a sex-specific therapeutic intervention for gliomas that is based upon dietary carbohydrate restriction. The investigators will integrate metabolomics tools and FDG-PET imaging to validate the ketogenic diet on a sex-specific basis.
Interventions
- DRUG BCNU
- PROCEDURE Ketogenic diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2022-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03591861
The ClinicalTrials.gov registry entry for NCT03591861 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BCNU is the first listed.
NCT03591861 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03591861 about?
NCT03591861 is a clinical study titled "Therapeutic Targeting of Sex Differences in Pediatric Brain Tumor Glycolysis". The investigators will develop the concept of a sex-specific therapeutic intervention for gliomas that is based upon dietary carbohydrate restriction. The investigators will integrate metabolomics tools and FDG-PET imaging to validate the ketogenic diet on a sex-specific basis.
What is the current status of trial NCT03591861?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2019-05-01. Estimated completion is 2022-11-01.
What interventions are being tested in trial NCT03591861?
The interventions under investigation include: BCNU (DRUG), Ketogenic diet (PROCEDURE).
Who is sponsoring clinical trial NCT03591861?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.